INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 13, 2003 |
Director
Trans History: 466
|
Director | Form 4 | Bona fide gift | 2,700 | -- | -- |
| Aug 13, 2003 |
Director
Trans History: 466
|
Director | Form 4 | Conversion of derivative security | 2,700 | -- | -- |
| Jul 28, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 5,762 | $14.92 | 308,586 |
| Jun 26, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 5,332 | $15.89 | 314,348 |
| Jun 26, 2003 |
Director
Trans History: 742
|
Director | Form 4 | Bona fide gift | 13,237 | $15.89 | 614,277 |
| May 07, 2003 |
Director
Trans History: 368
|
Director | Form 4 | Bona fide gift | 3,000 | $6.72 | 79,911 |
| Jan 13, 2003 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Bona fide gift | 250 | $19.65 | 15,482 |
| Aug 20, 2021 |
SVP Controller
Trans History: 306
|
SVP Controller | Form 4/A | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 8,719 | $664.85 | 19,020 |
| May 06, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4/A | Open market or private sale of non-derivative or derivative security | 12,018 | $263.15 | 114,750 |
| Dec 14, 2010 |
SVP F&A, CFO, Treas & Asst Sec
Trans History: 645
|
SVP F&A, CFO, Treas & Asst Sec | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 73,734 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.